Clear Eyes Itch Relief Eye Drops Recalled Nationwide Over Potential Contamination

In a recent development, the manufacturer of Clear Eyes Maximum Itchy Eye Relief has voluntarily recalled over 39,000 bottles of the product due to concerns regarding potential contamination. The US Food and Drug Administration (FDA) reported that the recall was initiated following a determination that the eye drops may not be sterile, posing risks to consumers’ health.

The specific product affected by this recall is Clear Eyes Maximum Itchy Eye Relief, which is available in 15 mL (0.5 fl oz) dropper bottles. According to the FDA, a total of 39,060 bottles were distributed across the United States. The recall was formally announced by Prestige Brands Holdings, the product’s manufacturer, on July 29, and later classified by the FDA as a Class II recall on August 14.

Under the classification of a Class II recall, the FDA indicates that the product could lead to temporary or medically reversible health issues, although the likelihood of serious adverse effects remains low. The presence of potential contamination in the eye drops raises concerns about their safety and efficacy, making it imperative for consumers to be vigilant.

Consumers who may have purchased these affected bottles are advised to check for specific identification details. The recalled products can be recognised by Lot number 2552A, along with an expiration date of September 30, 2027. Those in possession of the affected items should refrain from using them and consider disposing of them safely to ensure their health is not compromised.

Clear Eyes Maximum Itchy Eye Relief is designed to provide relief for irritation, burning, and mild dryness in the eyes. Its formulation includes active ingredients such as glycerin, naphazoline hydrochloride, and zinc sulfate. Additionally, it contains several inactive ingredients, including benzalkonium chloride, boric acid, edetate disodium, purified water, sodium chloride, and sodium citrate.

The FDA has confirmed that, despite the recall, the issue does not extend to all batches of Clear Eyes products, which continue to be available for consumer use. As the recall process remains ongoing, the health agency is encouraging consumers to stay informed and monitor any further announcements regarding the safety and availability of the eye drops.

Prestige Consumer Healthcare, the parent company of the brand, oversees a range of well-known over-the-counter health products, including Dramamine, Chloraseptic, and Summer’s Eve. The company is based in Tarrytown, New York, and has yet to release an official statement in response to the recall.

In light of this situation, consumers are urged to remain cautious when purchasing over-the-counter medication and health products. Regularly checking for recalls and monitoring safety advisories can help safeguard against unintentional exposure to potentially harmful products.

As the situation develops, experts remind users of medical products to report any adverse effects or concerns associated with recalled items to the appropriate health authorities. Engaging in proactive discussions around product safety contributes to overall public health awareness and ensures that consumers remain protected from undue risk.